- $2.84bn
- $2.91bn
- $510.17m
U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike
U.S. STOCKS ON THE MOVE-Energy shares, miners, Sysco
U.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta
U.S. STOCKS ON THE MOVE-Arm, Destiny Tech100, Terns Pharma
ADMA Biologics shares hit record high after FDA approves plasma yield process
ADMA Biologics shares hit record high after FDA approves plasma yield process
U.S. STOCKS ON THE MOVE-Revance Therapeutics, Insulet, StepStone
U.S. STOCKS ON THE MOVE-Bluebird bio, Panbela, Northern Trust
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Solaredge Technologies
U.S. STOCKS ON THE MOVE-Uniti Group, Pfizer, Moleculin Biotech
Brief: ADMA Biologics Announces Pricing Of Public Offering For $60 Million Of Common Stock
ADMA Biologics dips after pricing $60 mln share offering
Brief: ADMA Biologics Announces Proposed Public Offering Of Common Stock
Brief: ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate